Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to VenetoclaxJoan Montero, Andrew A. Lane, Jason Stephansky et al.|Cancer Discovery|2016Cited by 209
A neoantigen vaccine generates antitumour immunity in renal cell carcinomaDavid A. Braun, Toni K. Choueiri, Keerthi Shetty et al.|Nature|2025Cited by 162
Oral immune‐related adverse events associated with PD‐1 inhibitor therapy: A case seriesMuhammad Ali Shazib, Alessandro Villa, Sook‐Bin Woo et al.|Oral Diseases|2019Cited by 53
Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor–induced dermatologic adverse eventsSean Singer, Nicole R. LeBoeuf, Sally Tan et al.|Journal of the American Academy of Dermatology|2019Cited by 44